Similar articles

• Steroid-resistant protein-losing gastroenteropathy complicated with Sjögren's syndrome successfully treated with mizoribine.

  Izumi Y, Nakaoka K, Kamata M, Iwanaga N, Imadachi S, Kurohama H, Ito M, Migita K. Izumi Y, et al. Mod Rheumatol. 2018 Jul;28(4):716-720. doi: 10.3109/14397595.2016.1145570. Epub 2016 Apr 4. Mod Rheumatol. 2018. PMID: 26872871
• Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.

  Nakayamada S, Saito K, Umehara H, Ogawa N, Sumida T, Ito S, Minota S, Nara H, Kondo H, Okada J, Mimori T, Yoshifuji H, Sano H, Hashimoto N, Sugai S, Tanaka Y. Nakayamada S, et al. Mod Rheumatol. 2007;17(6):464-9. doi: 10.1007/s10165-007-0627-2. Epub 2007 Dec 20. Mod Rheumatol. 2007. PMID: 18084697 Clinical Trial.
• [Is rituximab a promising treatment for Sjögren's syndrome?].

  Devauchelle-Pensec V, Pers JO, Youinou P, Saraux A. Devauchelle-Pensec V, et al. Rev Med Interne. 2008 Dec;29(12):967-70. doi: 10.1016/j.revmed.2008.02.022. Epub 2008 Apr 9. Rev Med Interne. 2008. PMID: 18403066 French. No abstract available.
• Mizoribine: a new approach in the treatment of renal disease.

  Kawasaki Y. Kawasaki Y. Clin Dev Immunol. 2009;2009:681482. doi: 10.1155/2009/681482. Epub 2009 Dec 13. Clin Dev Immunol. 2009. PMID: 20052390 Free PMC article. Review.
• [Treatment of rheumatoid diseases].

  Wawrzynska-Pagowska J. Wawrzynska-Pagowska J. Wiad Lek. 1971 Jul 1;24(13):1269-77. Wiad Lek. 1971. PMID: 4257550 Review. Polish. No abstract available.